Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

243 views

Visitors from

US 53%·

AU 33%·

IN 7%·

GB 2%·

FR 1%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

Here's What to Expect From Kenvue's Next Earnings Report

April 22, 2026 at 08:52 AM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Skillman, New Jersey-based Kenvue Inc. (KVUE) operates as a consumer health company worldwide. Valued at $33.2 billion by market cap, the company offers a consumer health portfolio in self-care, skin health & beauty, and essential health products. The world’s largest pure-play consumer health company is expected to announce its fiscal first-quarter earnings for 2026 in the near term.

Ahead of the event, analysts expect KVUE to report a profit of $0.27 per share on a diluted basis, up 12.5% from $0.24 per share in the year-ago quarter. The company surpassed the consensus estimate in each of the last four quarters.

More Top Stocks Daily: Go behind Wall Street’s hottest headlines with Barchart’s Active Investor newsletter.

For the full year, analysts expect KVUE to report EPS of $1.10, up 1.9% from $1.08 in fiscal 2025. Its EPS is expected to rise 5.5% year over year to $1.16 in fiscal 2027.

KVUE stock has underperformed the S&P 500 Index’s ($SPX) 33.6% gains over the past 52 weeks, with shares down 22.3% during this period. Similarly, it underperformed the State Street Consumer Staples Select Sector SPDR ETF’s (XLP) marginal returns over the same time frame.

On Feb. 17, KVUE shares closed down by 1.6% after reporting its Q4 results. Its adjusted EPS of $0.27 topped Wall Street expectations of $0.22. The company’s revenue was $3.8 billion, topping Wall Street forecasts of $3.7 billion.

Analysts’ consensus opinion on KVUE stock is cautious, with a “Hold” rating overall. Out of 13 analysts covering the stock, one advises a “Strong Buy” rating, and 12 give a “Hold.” KVUE’s average analyst price target is $19.09, indicating a potential upside of 10.3% from the current levels.

On the date of publication, Neha Panjwani did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.

More news from Barchart

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article